Home » Top-tier productive scientific complex
The Center for Genetic Engineering and Biotechnology (CIGB) is a company with a management system for scientific research and innovation, development, production and marketing of high value-added products, applications, drugs and vaccines.
Our innovative products and vaccines focus on key areas of the biomedical sector such as the diagnosis, treatment and prevention of infectious, autoimmune, cardiovascular, cerebrovascular, oncological, dermatological, hematological, neurological, gastrointestinal, diabetes and scarring diseases. Some of these diseases: hepatitis B and C, type II diabetes mellitus, acute hemorrhoidal disease, COVID-19, diseases caused by Haemophilus influenzae type b, diphtheria, tetanus, whooping cough, and diabetic foot ulcers.
The CIGB also works on the development of new businesses with foreign investment, and expands its links with other entities and with universities.